Our People

Dr Chantal Donovan is a respiratory pharmacologist and Head of the ImmunoPharmacology Research Group (IPRG) at the Woolcock Institute of Medical Research and University of Technology Sydney (UTS).

She completed her PhD in Pharmacology at The University of Melbourne in 2015 and postdoctoral training at Monash University and the University of Newcastle (Immunology & Microbiology). She was awarded an NHMRC Early Career Fellowship (2017-2020) and NHMRC New Investigator grant (2018-2021) and was recruited to UTS as a faculty member in 2019.

Her research specialises in drug discovery and pharmacological testing of novel treatments for lung diseases, using novel pre-clinical models of asthma, chronic obstructive pulmonary disease, and lung cancer, combined with cutting-edge techniques to measure lung physiology, pharmacology and immunological mechanisms (e.g. precision cut lung slices, flow cytometry).

She sits on the Board of Directors of Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and convenes the ASCEPT Respiratory and Inflammation Special Interest Group. She is also the 2025 winner of the American Thoracic Society Respiratory Structure and Function Ann Woolcock Memorial Award.

View Chantal's academic profile